Atrial fibrillation and coronavirus infection

• Published in: Europace (London, England) England), 2022-05, Vol.24 (Supplement_1)
• Main Authors: Sychov, OS, Talaieva, TV, Gavrilenko, TI, Romanova, OM, Hetman, TV, Stasyshena, OV, Ilchyshyna, O YA
• Format: Article
• Language: English
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euac053.611

Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): NSC M.D Strazhesko Institute of Cardiology Coronavirus infection (CI) needs to be specified in terms of the impact on the development of first-onset arrhythmia episodes and the worsening of the course of pre-existing arrhythmias and conduction disturbances. The aim of our study was to examine the features of the most common and potentially dangerous arrhythmia - atrial fibrillation (AF) in patients with COVID-19 infection (CI). Research methods in this fragment of work the estimation of clinical and anamnestic characteristics of patients (pts) and a course of a disease is resulted. Results We studied 29 pts, including 9 men and 20 women, aged 65.7 + 1.8 years, who 3.8 + 0.6 months ago underwent CI, and were admitted to our clinic with a diagnosis of atrial fibrillation ( AF): 18 pts with paroxysmal, 8 pts with persistent and three people with permanent forms of this arrhythmia. Of these, 18 (62.1%) had AF before COVID-19 (study group 1), and 11 (37.9%) pts had this arrhythmia after CI (study group 2). In pts of the 1st group after CI there was an increased duration of AF paroxysm in all 15 pts with paroxysmal and persistent forms of AF from 1.9 + 0.4 to 59.1 + 2.0 days (p (0.001). In favor of the latter is the fact that in these patients the frequency of arrhythmia paroxysms increased from 2.5 + 0.4 times a year to 53.6 + 1.9 during the same time (up to almost once a week) (p